[MARKET ANALYSIS] T-note futures remain subdued amid oil-related inflationary pressures and as supply looms, while overnigh cash treasuries trade is closed due to the Tokyo holiday
Newsquawk Staff ·
USTs: -2.5 ticks
- Remained subdued following the prior day's declines as the recent rally in oil lifted yields and stoked inflationary concerns, with demand overnight not helped by the closure of cash treasuries trade due to the Tokyo holiday, while US supply is also scheduled later.
Bunds: -12 ticks
- Extended beneath the prior day's trough amid the upside in energy prices and with a EUR 6bln Bobl issuance due today, ahead of tomorrow's EUR 2bln Bund auction.
What it means
Sessions where futures drift on oil-led inflation repricing against a backdrop of looming supply follow a familiar pattern: the energy impulse lifts breakevens and the long end, while the auction concession adds a separate, mechanical source of pressure that typically resolves around the sale itself rather than persisting beyond it. The distinction worth drawing is between the inflation channel and the supply channel: the former tracks crude and tends to reverse if energy stalls, the latter is calendar-driven and often sees cheapening into the auction followed by a partial retracement once the paper clears. A Tokyo holiday closure is a recurring feature of the overnight session and has historically meant thin cash liquidity, with futures carrying the price discovery and moves prone to exaggeration until Japanese participants return. On the European side, the sequencing of shorter-dated issuance ahead of the benchmark auction is a standard pattern in which the front supply sets the tone and the later sale determines whether the cheapening holds. The tells are the auction tails and bid-to-covers, whether crude holds its bid into the session, and how the market trades once full cash liquidity resumes.
- Week in Focus 26-30th October 2026: FOMC, BoC, RBNZ, ECB, BoJ Policy Decisions, US PCE
- US Midterm Preview: Democrats Favoured to Flip the House, Senate Too Close to Call
- Newsquawk Weekly Economic Release 26th - 30th October 2026
- Newsquawk European Market Wrap - 23rd October 2026
- Daily US Equity Opening News: SPCX explores access to 80K US cell sites; OpenAI nears USD 30bln funding at $1.25T valuation
Related headlines
- Newsquawk Daily European Opening News - 23rd October 202617 hours ago
- Daily US Equity Opening News - SPCX explores access to 80K US cell sites; OpenAI nears USD 30bln funding at USD 1.25tln valuation; AAPL foldable iPhone launches; SKHY cancels Solidigm Nasdaq IPO plans; WDC beat and raise14 hours ago
- CRUDE WRAP: WTI (Z6) SETTLES USD 3.80 HIGHER AT USD 103.27/BBL; BRENT (Z6) SETTLES USD 3.55 HIGHER AT USD 116.72/BBL4 hours ago
- Daily US Earnings Estimates: 26th October 2026: VZ, WELL5 hours ago
- US EQUITY OPEN: Breadth poor at the open: Energy leads gains on oil rally, Tech sees slight bounce8 hours ago
- [MARKET ANALYSIS] European bourses broadly lower; Volvo Cars trades at its lowest ever following dire results13 hours ago
- [MARKET ANALYSIS] Crude benchmarks edge higher as the geopolitical environment remains tense13 hours ago
- European Pre-Market Summary 23rd October 2026: Futures modestly firmer. Updates dominated by a poor Volvo Cars outing and a mixed Kering report16 hours ago
- American Express (AXP) Q3 2026 (USD): EPS 5.42 (exp. 4.50), Revenue 20.1bln (exp. 20.1bln)11 hours ago
- European Movers: L'Oreal (OR FP) +4.8%, Holcim (HOLN SW) +4.5%, Hexagon (HEXAB SS) +3.0%, Eni (ENI IM) +2.3%, Kering (KER FP) -11.0%, Volvo Car (VOLCARB SS) -3.3%15 hours ago
- Additional European Equity News - 23rd October 202616 hours ago
- US President Trump says we’re close to ending, I hope, the Russia-Ukraine war3 hours ago
- White House says President Trump has further modified Canadian products subject to tariffs under Section 338; tariff changes will take effect on 30th October 20263 hours ago
- US President Trump, on Iran, says we may do another operation against Iran; doubts Iran will say ‘let’s get down to business’3 hours ago
- US FDA approves subcutaneous induction regimen for AbbVie’s (ABBV) Skyrizi for adults with moderately to severely active Crohn’s disease3 hours ago